Single-source·Aug 28, 2026·1 sources analyzed
Aficamten trial brings positive news for patients living with non-obstructive hypertrophic cardiomyopathy
Aficamten trial brings positive news for patients living with non-obstructive hypertrophic cardiomyopathy (medicalxpress)

Image: medicalxpress
